By Josh Beckerman
Certara Inc. shares fell 15% to $17.24 after the biosimulation company said certain stockholders including EQT AB plan to sell 7 million shares.
On Tuesday, Certara said second-quarter revenue rose 18% to $82.8 million, but added that it expects foreign exchange impact and softness in regulatory services to continue in the second half of the year.
Write to Josh Beckerman at email@example.com
(END) Dow Jones Newswires
August 12, 2022 13:20 ET (17:20 GMT)Copyright (c) 2022 Dow Jones & Company, Inc.